Literature DB >> 6971716

Effect of bypass surgery on survival in patients in low- and high-risk subgroups delineated by the use of simple clinical variables.

K Detre, P Peduzzi, M Murphy, H Hultgren, J Thomsen, A Oberman, T Takaro.   

Abstract

A multivariate risk function was developed on data from all 508 medical patients in the Veterans Administration (VA) randomized study of coronary bypass surgery. The variables, in order of importance, were ST-segment depression on resting ECG, history of myocardial infarction, history of hypertension and New York Heart Association functional classification III or IV. These noninvasive variables have been reported to be risk factors in natural-history studies of coronary heart disease (CHD). Applying the risk function to medical and surgical patients of the 1972-1974 cohort yielded a 5-year probability of dying for each patient. Investigation of treatment effects in approximate terciles obtained by collapsing the probability distribution into low-, middle- and high-risk groups showed that surgery was beneficial for patients in the high-risk tercile even after removal of patients with left main coronary artery disease (17% surgical vs 34% medical mortality at 5 years; p less than 0.01). This finding was accentuated when patients in the 10 hospitals with the lowest operative mortality (3.3%) were compared. Mortality results in the low-risk tercile favored medical treatment (medical vs surgical mortality 7% vs 17%; p less than 0.05). The risk function predicted mortality well not only for te VA medical group, but also for an independent symptomatic CHD population from the University of Alabama arteriography registry. This report further delineates the advantages and limitations of coronary bypass surgery in CHD patients with chronic stable angina.

Entities:  

Mesh:

Year:  1981        PMID: 6971716     DOI: 10.1161/01.cir.63.6.1329

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  15 in total

Review 1.  The value of quantitative myocardial perfusion imaging with positron emission tomography in coronary artery disease.

Authors:  W Wijns; P G Camici
Journal:  Herz       Date:  1997-04       Impact factor: 1.443

2.  Non-invasive magnetic resonance imaging of coronary bypass grafts. comparison of the haste- and navigator techniques with conventional coronary angiography.

Authors:  Th Wittlinger; T Voigtländer; K F Kreitner; P Kalden; M Thelen; J Meyer
Journal:  Int J Cardiovasc Imaging       Date:  2002-12       Impact factor: 2.357

3.  Coronary artery bypass in perspective.

Authors:  R J Hall
Journal:  Tex Heart Inst J       Date:  1989

Review 4.  Relief of Ischemia in Ischemic Cardiomyopathy.

Authors:  Francesco Moroni; Zachary Gertz; Lorenzo Azzalini
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 2.931

5.  STICH (Surgical Treatment for Ischemic Heart Failure) trial enrollment.

Authors:  Robert H Jones; Harvey White; Eric J Velazquez; Linda K Shaw; Ricardo Pietrobon; Julio A Panza; Robert O Bonow; George Sopko; Christopher M O'Connor; Jean-Lucien Rouleau
Journal:  J Am Coll Cardiol       Date:  2010-08-03       Impact factor: 24.094

Review 6.  The practical implications of the coronary artery surgery trials.

Authors:  D G Julian
Journal:  Br Heart J       Date:  1985-10

7.  Myocardial revascularization. Historical considerations.

Authors:  R J Hall
Journal:  Tex Heart Inst J       Date:  1994

8.  Coronary artery bypass grafting for the reduction of mortality: an analysis of the trials.

Authors:  J R Hampton
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-03

9.  Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS).

Authors:  I Ringqvist; L D Fisher; M Mock; K B Davis; H Wedel; B R Chaitman; E Passamani; R O Russell; E L Alderman; N T Kouchoukas; G C Kaiser; T J Ryan; T Killip; D Fray
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

10.  Factors influencing survival and mode of death in severe chronic ischaemic cardiac failure.

Authors:  D R Glover; W A Littler
Journal:  Br Heart J       Date:  1987-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.